BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 35508681)

  • 1. Trends in Preoperative Chemotherapy Utilization for Proximal Pancreatic Cancer: Are We Making Progress?
    Mellado S; Vega EA; Abudalou M; Kutlu OC; Salehi O; Li M; Kozyreva O; Freeman R; Conrad C
    J Gastrointest Surg; 2022 Aug; 26(8):1-7. PubMed ID: 35508681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of chemotherapy sequencing on resectable pancreatic cancer by stage.
    Vega EA; Kutlu OC; Salehi O; Alarcon SV; Abudalou M; Kozyreva O; Krishnan S; Lee D; Freeman R; Conrad C
    Surg Oncol; 2022 Mar; 40():101694. PubMed ID: 34973593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minimally Invasive Pancreaticoduodenectomy Does Not Improve Use or Time to Initiation of Adjuvant Chemotherapy for Patients With Pancreatic Adenocarcinoma.
    Nussbaum DP; Adam MA; Youngwirth LM; Ganapathi AM; Roman SA; Tyler DS; Sosa JA; Blazer DG
    Ann Surg Oncol; 2016 Mar; 23(3):1026-33. PubMed ID: 26542590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative Chemotherapy for Pancreatic Cancer Improves Survival and R0 Rate Even in Early Stage I.
    Vega EA; Kutlu OC; Salehi O; James D; Alarcon SV; Herrick B; Krishnan S; Kozyreva O; Conrad C
    J Gastrointest Surg; 2020 Oct; 24(10):2409-2415. PubMed ID: 32394126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perioperative chemotherapy is associated with a survival advantage in early stage adenocarcinoma of the pancreatic head.
    Lutfi W; Talamonti MS; Kantor O; Wang CH; Liederbach E; Stocker SJ; Bentrem DJ; Roggin KK; Winchester DJ; Marsh R; Prinz RA; Baker MS
    Surgery; 2016 Sep; 160(3):714-24. PubMed ID: 27422328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and oncologic efficacy of robotic compared to open pancreaticoduodenectomy after neoadjuvant chemotherapy for pancreatic cancer.
    Nassour I; Tohme S; Hoehn R; Adam MA; Zureikat AH; Alessandro P
    Surg Endosc; 2021 May; 35(5):2248-2254. PubMed ID: 32440928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoadjuvant external beam radiation is associated with No benefit in overall survival for early stage pancreatic cancer.
    Lutfi W; Talamonti MS; Kantor O; Wang CH; Stocker SJ; Bentrem DJ; Roggin KK; Winchester DJ; Marsh R; Prinz RA; Baker MS
    Am J Surg; 2017 Mar; 213(3):521-525. PubMed ID: 28089341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mortality and Survival Among Octogenarians with Localized Pancreatic Head Cancer: a National Cancer Database Analysis.
    Hue JJ; Bingmer K; Sugumar K; Ocuin LM; Rothermel LD; Winter JM; Ammori JB; Hardacre JM
    J Gastrointest Surg; 2021 Oct; 25(10):2582-2592. PubMed ID: 33634421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of Adjuvant Chemotherapy Use and Association With Survival in Adults 80 Years and Older With Pancreatic Adenocarcinoma.
    Mehtsun WT; McCleary NJ; Maduekwe UN; Wolpin BM; Schrag D; Wang J
    JAMA Oncol; 2022 Jan; 8(1):88-95. PubMed ID: 34854874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with inability to return to intended oncologic treatment in pancreatic cancer.
    Mickel TA; Kutlu OC; Silberfein EJ; Hsu C; Chai CY; Fisher WE; Van Buren G; Camp ER
    Am J Surg; 2022 Jul; 224(1 Pt B):635-640. PubMed ID: 35249728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of complications on oncologic outcomes after pancreaticoduodenectomy for pancreatic cancer.
    Le AT; Huang B; Hnoosh D; Saeed H; Dineen SP; Hosein PJ; Durbin EB; Kudrimoti M; McGrath PC; Tzeng CD
    J Surg Res; 2017 Jun; 214():1-8. PubMed ID: 28624029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymph Node Ratio in Pancreatic Adenocarcinoma After Preoperative Chemotherapy vs. Preoperative Chemoradiation and Its Utility in Decisions About Postoperative Chemotherapy.
    Swords DS; Francis SR; Lloyd S; Garrido-Laguna I; Mulvihill SJ; Gruhl JD; Christensen MC; Stoddard GJ; Firpo MA; Scaife CL
    J Gastrointest Surg; 2019 Jul; 23(7):1401-1413. PubMed ID: 30187332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of hypofractionated and standard fractionated chemoradiation before pancreatoduodenectomy for pancreatic ductal adenocarcinoma.
    Cloyd JM; Crane CH; Koay EJ; Das P; Krishnan S; Prakash L; Snyder RA; Varadhachary GR; Wolff RA; Javle M; Shroff RT; Fogelman D; Overman M; Wang H; Maitra A; Lee JE; Fleming JB; Katz MH
    Cancer; 2016 Sep; 122(17):2671-9. PubMed ID: 27243381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Splenic and PB immune recovery in neoadjuvant treated gastrointestinal cancer patients.
    Cole KE; Ly QP; Hollingsworth MA; Cox JL; Fisher KW; Padussis JC; Foster JM; Vargas LM; Talmadge JE
    Int Immunopharmacol; 2022 May; 106():108628. PubMed ID: 35203041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in receipt of multimodality therapy by race, insurance status, and socioeconomic disadvantage in patients with resected pancreatic cancer.
    Hao S; Mitsakos A; Irish W; Tuttle-Newhall JE; Parikh AA; Snyder RA
    J Surg Oncol; 2022 Aug; 126(2):302-313. PubMed ID: 35315932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative cholangitis is an independent risk factor for mortality in patients after pancreatoduodenectomy for pancreatic cancer.
    Darnell EP; Wang TJ; Lumish MA; Hernandez-Barco YG; Weniger M; Casey BW; Qadan M; Lillemoe KD; Ferrone CR; Fernandez-Del Castillo C; Krishnan K
    Am J Surg; 2021 Jan; 221(1):134-140. PubMed ID: 32847686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perioperative blood transfusions for vein resection during pancreaticoduodenectomy for pancreatic adenocarcinoma: Identification of clinical targets for optimization.
    Snyder RA; Prakash LR; Nogueras-Gonzalez GM; Kim MP; Aloia TA; Vauthey JN; Lee JE; Fleming JB; Katz MHG; Tzeng CD
    HPB (Oxford); 2019 Jul; 21(7):841-848. PubMed ID: 30501986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of textbook oncologic outcomes following pancreaticoduodenectomy for pancreatic adenocarcinoma.
    Sweigert PJ; Eguia E; Baker MS; Paredes AZ; Tsilimigras DI; Dillhoff M; Ejaz A; Cloyd J; Tsung A; Pawlik TM
    J Surg Oncol; 2020 May; 121(6):936-944. PubMed ID: 32124437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The differential effect of neoadjuvant chemotherapy and chemoradiation on nodal downstaging in pancreatic adenocarcinoma.
    Altimari M; Wells A; Abad J; Chawla A
    Pancreatology; 2023 Nov; 23(7):805-810. PubMed ID: 37599170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The treatment sequence may matter in patients undergoing pancreatoduodenectomy for early stage pancreatic cancer in the era of modern chemotherapy.
    Watson MD; Thompson KJ; Musselwhite LW; Hwang JJ; Baker EH; Martinie JB; Vrochides D; Iannitti DA; Ocuin LM
    Am J Surg; 2021 Jul; 222(1):159-166. PubMed ID: 33121658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.